Evidence method
Level · gp.fundamentals.debt_to_revenue
74508.51% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TGTX · Sep 30, 2022
TG THERAPEUTICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001558370-22-017180General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
4.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-36696.81% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-95.37% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-37194.68% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22128.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7446.81% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20235/7 normalizedLevel 3Sep 30, 20235/8 normalizedLevel 3Dec 31, 20235/9 normalizedLevel 3Mar 31, 20244/7 normalizedLevel 3Jun 30, 20245/7 normalizedLevel 3Sep 30, 20245/7 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 11607.24%
- Current
- 74508.51%
- Delta
- 62901.27%
- Previous
- 0.00%
- Current
- 4.26%
- Delta
- 4.26%
- Previous
- -8268.69%
- Current
- -36696.81%
- Delta
- -28428.12%
- Previous
- -61.55%
- Current
- -95.37%
- Delta
- -33.82%
- Previous
- -6555.72%
- Current
- -37194.68%
- Delta
- -30638.96%
- Previous
- 4524.24%
- Current
- 22128.72%
- Delta
- 17604.48%
- Previous
- -168.35%
- Current
- 7446.81%
- Delta
- 7615.16%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TGTX Fundamental State →Has State · TG THERAPEUTICS, INC. →Transitioned To · TGTX Fundamental State →Transitioned To · TGTX BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · TGTX CAPEX_INTENSITY_INCREASED →Transitioned To · TGTX CASH_GENERATION_DECREASED →Transitioned To · TGTX GROWTH_DECREASED →Transitioned To · TGTX PROFITABILITY_DECREASED →Transitioned To · TGTX R_AND_D_INTENSITY_INCREASED →Transitioned To · TGTX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.